Shifa Biomedical Corporation
Records under this name other than the patents Shifa Biomedical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 2 of 2 · Back to Shifa Biomedical Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,131,637 | ANTI-PCSK9 Compounds and Methods for the Treatment And/Or Prevention of Cardiovascular Diseases Formerly held Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 9,682,085 | Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases Lapsed on the fee record Ended Jun 20, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | USPTO record |